TCA
RMD icon

Trifecta Capital Advisors’s ResMed RMD Stock Holding History

Trifecta Capital Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7
Closed -$1.92K – 412
2025
Q3 		$1.92K Hold
7
– – ﹤0.01% 340
2025
Q2 		$1.81K Hold
7
– – ﹤0.01% 350
2025
Q1 		$1.57K Hold
7
– – ﹤0.01% 333
2024
Q4 		$1.6K Hold
7
– – ﹤0.01% 328
2024
Q3 		$1.71K Hold
7
– – ﹤0.01% 329
2024
Q2 		$1.34K Hold
7
– – ﹤0.01% 353
2024
Q1 		$1.39K Hold
7
– – ﹤0.01% 344
2023
Q4 		$1.21K Buy
+7
New +$1.08K ﹤0.01% 381

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Trifecta Capital Advisors's RMD Position: Q4 2025 in Review

Trifecta Capital Advisors sold out of ResMed (RMD) in Q4 2025, closing a stake of 7 shares — an estimated $1.92K sold.

Trifecta Capital Advisors first reported a position in RMD in Q4 2023 and held it in 8 quarters. The position peaked at $1.92K in Q3 2025. 946 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Trifecta Capital Advisors reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Trifecta Capital Advisors sold 7 ResMed shares in Q4 2025, an estimated $1.92K.
  • Trifecta Capital Advisors first reported a position in ResMed in Q4 2023 and held it in 8 quarters.
  • Trifecta Capital Advisors's ResMed position peaked at $1.92K in Q3 2025.
  • 946 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Trifecta Capital Advisors's 13F filing for Q4 2025, filed 30 Jan 2026.